The characterization of adrenal insufficiency and identification of its risk factors in patients with plasma cell dyscrasias

American Journal of Hematology

Volumn 90, Issue 10, 2015, Pages E202-E203

  Tremblay, Douglas ^a   choudhury, Nadim ^a   Ravikumar, Aarti ^a   Levine, Alice C ^a   Chari, Ajai ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE;

ADRENAL INSUFFICIENCY; ADULT; AGED; AMYLOIDOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CORTICOTROPIN BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LETTER; MALE; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; PROVOCATION TEST; RETROSPECTIVE STUDY; RISK FACTOR; COMPLICATION; MIDDLE AGED; PARAPROTEINEMIAS;

ADRENAL INSUFFICIENCY; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARAPROTEINEMIAS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84942193555     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24118     Document Type: Letter

References (6)

1. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008;111:2516-2520.
2. Henzen C, Suter A, Lerch E, et al. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. Lancet 2000;355:542-545.
3. Einaudi S, Bertorello N, Masera N, et al. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2008;50:537-541.
4. Dispenzieri A, Gertz MA, Buadi F. What do I need to know about immunoglobulin light chain (AL) amyloidosis? Blood Rev 2012;26:137-154.
5. Van Waas M, Neggers SJCMM, Van Eck JP, et al. Adrenal function in adult long-term survivors of nephroblastoma and neuroblastoma. Eur J Cancer 2012;48:1159-1166.
6. Nucci M, Anaissie E. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents. Clin Infect Dis 2009;49:1211-1225.